Cargando…
Metabolic reprogramming by PCK1 promotes TCA cataplerosis, oxidative stress and apoptosis in liver cancer cells and suppresses hepatocellular carcinoma
Phosphoenolpyruvate carboxykinase (PEPCK or PCK) catalyzes the first rate-limiting step in hepatic gluconeogenesis pathway to maintain blood glucose levels. Mammalian cells express two PCK genes, encoding for a cytoplasmic (PCPEK-C or PCK1) and a mitochondrial (PEPCK-M or PCK2) isoforms, respectivel...
Autores principales: | Liu, Meng-Xi, Jin, Lei, Sun, Si-Jia, Liu, Peng, Feng, Xu, Cheng, Zhou-Li, Liu, Wei-Ren, Guan, Kun-Liang, Shi, Ying-Hong, Yuan, Hai-Xin, Xiong, Yue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5860930/ https://www.ncbi.nlm.nih.gov/pubmed/29335519 http://dx.doi.org/10.1038/s41388-017-0070-6 |
Ejemplares similares
-
Glutamate and asparagine cataplerosis underlie glutamine addiction in
melanoma
por: Ratnikov, Boris, et al.
Publicado: (2015) -
Phosphoenolpyruvate carboxykinase and the critical role of cataplerosis in the control of hepatic metabolism
por: Hakimi, Parvin, et al.
Publicado: (2005) -
Glycolytic reprogramming through PCK2 regulates tumor initiation of prostate cancer cells
por: Zhao, Jiangsha, et al.
Publicado: (2017) -
Transcriptomic changes associated with PCK1 overexpression in hepatocellular carcinoma cells detected by RNA-seq
por: Xiang, Jin, et al.
Publicado: (2019) -
Metformin can mitigate skeletal dysplasia caused by Pck2 deficiency
por: Li, Zheng, et al.
Publicado: (2022)